Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Venous Thromboembolism in Cancer Patients”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableUnknownNCT02017743
What this trial is testing

Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Trio Grup Clinical Research 200
Large-scale testing (Phase 3)Looking for participantsNCT05920343
What this trial is testing

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Who this might be right for
Venous ThromboembolismUrologic Cancer
Ottawa Hospital Research Institute 120
Not applicableStudy completedNCT04979780
What this trial is testing

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsProphylaxis of Recurrent Venous Thromboembolism in Cancer Patients
Bayer 3,708
Not applicableLooking for participantsNCT06894576
What this trial is testing

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Ottawa Hospital Research Institute 1,000
Large-scale testing (Phase 3)Study completedNCT02066454
What this trial is testing

Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs

Who this might be right for
MyelomaVenous Thromboembolism
University Hospital, Grenoble 108
Not applicableUnknownNCT05229471
What this trial is testing

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study

Who this might be right for
CancerVenous ThromboembolismRecurrence
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 220
Not applicableStudy completedNCT02922543
What this trial is testing

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Who this might be right for
Multiple Myeloma
Celgene 361
Post-approval studies (Phase 4)Study completedNCT02958969
What this trial is testing

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Who this might be right for
Venous ThromboembolismMultiple Myeloma
Gregory Piazza 50
Not applicableStudy completedNCT05461807
What this trial is testing

An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsVenous ThromboembolismCancer
Bayer 2,437
Testing effectiveness (Phase 2)Ended earlyNCT03195010
What this trial is testing

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+11 more
Fred Hutchinson Cancer Center 4
Not applicableStudy completedNCT05112666
What this trial is testing

Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer Patients
Bayer 2,601
Not applicableLooking for participantsNCT06714734
What this trial is testing

Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT

Who this might be right for
Venous Thromboembolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Large-scale testing (Phase 3)Study completedNCT02746185
What this trial is testing

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

Who this might be right for
NeoplasmVenous Thromboembolism
Assistance Publique - Hôpitaux de Paris 159
Large-scale testing (Phase 3)Study completedNCT05625932
What this trial is testing

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticThromboembolism
Galician Research Group on Digestive Tumors 232
Testing effectiveness (Phase 2)Study completedNCT00952380
What this trial is testing

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Who this might be right for
Venous Thromboembolism
Pfizer 38
Large-scale testing (Phase 3)Ended earlyNCT05171049
What this trial is testing

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 1,150
Not applicableNot Yet RecruitingNCT07372716
What this trial is testing

Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

Who this might be right for
ThrombosisCancerThrombosis, Deep Vein+3 more
Ottawa Hospital Research Institute 700
Not applicableStudy completedNCT01362933
What this trial is testing

National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients

Who this might be right for
NeoplasmsVenous Thromboembolism
Floralis 502
Not applicableStudy completedNCT03114618
What this trial is testing

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

Who this might be right for
Cancer-associated ThrombosisGenetic Predisposition
Andres muñoz 416
Not applicableStudy completedNCT01602445
What this trial is testing

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute 700
Load More Results